Bioscience Animal Health PCL (BKK:BIS)

Market Cap	646.84M -23.1%
Revenue (ttm)	2.20B -5.5%
Net Income	37.39M -46.7%
EPS	0.12 -46.7%
Shares Out	314.00M
PE Ratio	17.30
Forward PE	n/a
Dividend	0.12 (6.00%)
Ex-Dividend Date	Apr 29, 2026

Volume	79,200
Open	2.020
Previous Close	2.000
Day's Range	2.000 - 2.060
52-Week Range	1.700 - 3.120
Beta	0.54
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About BKK:BIS

Bioscience Animal Health Public Company Limited, together with its subsidiaries, manufactures, imports, and distributes pharmaceutical supplies, devices, equipment, and products for livestock and companion animals in Thailand and internationally. The company offers antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. In addition, the company offers farm production consultant; disease prevention a...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Employees: 140
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BIS

Financial Performance

In 2025, BKK:BIS's revenue was 2.25 billion, a decrease of -3.01% compared to the previous year's 2.32 billion. Earnings were 38.47 million, a decrease of -40.85%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error